Form 4: CVS Health Executive Samrat S. Khichi Reports Changes in Beneficial Ownership
SEC Form 4 Filing
EVP, CPO and General Counsel of CVS Health, Samrat S. Khichi, reports acquisition and disposal of CVS stock and stock options.
Summary
- On April 1, 2025, Samrat S. Khichi, EVP, CPO and General Counsel of CVS Health Corp, reported transactions involving CVS common stock and derivative securities.
- Khichi surrendered 1,548 shares of common stock to cover withholding taxes due upon the vesting of restricted stock units at a price of $67.98 per share.
- He also acquired 16,181 restricted stock units at a price of $67.98 per share, bringing his total holdings to 41,569 restricted stock units.
- Additionally, Khichi acquired 68,621 stock options with an exercise price of $67.98, exercisable in four equal annual installments starting April 1, 2026, and expiring on April 1, 2035.
- Following these transactions, Khichi directly owns 21,700 shares of common stock and 68,621 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Positives
- The acquisition of restricted stock units and stock options indicates confidence in the company's future performance.
Future Outlook
The restricted stock units lapse in four equal installments, commencing 4/1/2026. The stock options become exercisable in four equal annual installments, commencing on 4/1/2026 and expire on 4/1/2035.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding the executive's stake in the company.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Vesting schedules and exercise prices are typical components of these compensation plans.
- The details disclosed are consistent with standard reporting practices for insider transactions.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of earliest transaction: surrender of shares for taxes, acquisition of restricted stock units, and acquisition of stock options. |
| 04/01/2026 | Commencement date for the vesting of restricted stock units in four equal installments. |
| 04/01/2026 | Commencement date for the exercisability of stock options in four equal annual installments. |
| 04/01/2035 | Expiration date of the acquired stock options. |
| 04/03/2025 | Date of signature for the Form 4 filing. |
Keywords
CVS Health, Samrat S. Khichi, Beneficial Ownership, Stock Options, Restricted Stock Units, Form 4, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.